A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT03997539 · UNKNOWN
Trial details
- NCT number
- NCT03997539
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2021-06-30
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.